glp-1 nobel prize Appetite-regulating hormones in focus as first Prizes fall GLP-1 | Summary

Avoids blend confusion: no pre-mix claims or unknown ratios

Pharmacologic approaches to glycemic treatment: standards of care in Diabetes2025

I'll admit that part of what I love is the packaging

The drug has been a cornerstone in ADHD management, offering symptomatic relief and improving quality of life for many patients

We just got trademarked

Semaglutide, liraglutide, and tirzepatide are no longer on the shortage list, but some companies have continued to provide the drugs to patients under exceptions for 'personalised' treatments under a framework known as Section 503A, which allows compounders to make compounds in small quantities for patients whose needs - they claim - are not met by a standard formulation